Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Recurrence following initial treatment for venous thromboembolism is a significant cause of morbidity and mortality. Balancing the risks of recurrence against the risks of long-term anticoagulation is essential for optimizing patient outcomes.

Original publication

DOI

10.12968/hmed.2015.76.2.72

Type

Conference paper

Publication Date

02/2015

Volume

76

Pages

72 - 77

Keywords

Adult, Anticoagulants, Decision Support Techniques, Female, Humans, Male, Middle Aged, Neoplasms, Pulmonary Embolism, Recurrence, Risk Assessment, Secondary Prevention, Thrombophilia, Venous Thrombosis